Lolai Ikromzoda
Lolai Ikromzoda
PhD Candidate, Sabanci University
Verified email at sabanciuniv.edu
Title
Cited by
Cited by
Year
Engineering antigen‐specific NK cell lines against the melanoma‐associated antigen tyrosinase via TCR gene transfer
A Parlar, EC Sayitoglu, D Ozkazanc, AM Georgoudaki, C Pamukcu, ...
European journal of immunology 49 (8), 1278-1290, 2019
82019
Circulating LL37 targets plasma extracellular vesicles to immune cells and intensifies Behçet’s disease severity
T Kahraman, G Gucluler, I Simsek, FC Yagci, M Yildirim, C Ozen, A Dinc, ...
Journal of extracellular vesicles 6 (1), 1284449, 2017
52017
Engineering antigen-specific natural killer cells against the melanoma-associated antigen tyrosinase via TCR gene transfer.
A Parlar, EC Sayitoglu, C Pamukcu, AM Georgoudaki, D Ozkazanc, ...
CANCER IMMUNOLOGY RESEARCH 8 (4), 49-50, 2020
2020
Abstract A21: Engineering antigen-specific natural killer cells against the melanoma-associated antigen tyrosinase via TCR gene transfer
A Parlar, EC Sayitoglu, C Pamukcu, AM Georgoudaki, D Ozkazanc, ...
Cancer Immunology Research 8 (4 Supplement), A21-A21, 2020
2020
Engineering antigen-specific NK cells via TCR gene transfer: A novel source for adoptive immunotherapy
A Parlar, C Pamukcu, D Özkazanç, M Aras, C Dahlberg, M Chrobok, ...
Mary Ann Liebert 28 (12), A31-A32, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–5